# Elitra Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/elitra-pharmaceuticals

- Industry: Biotechnology
- Headquarters: San Diego, US
- Total disclosed funding: $22M
- Latest round: Series C (Aug 23, 2000)
- Investors on record: 10

## About

Elitra Pharmaceuticals engages in discovering, developing, and commercializing the next generation of antimicrobial drugs that target essential gene products of pathogenic organisms.

## Funding rounds

- Series C, Aug 23, 2000, $22M — Enterprise Partners Venture Capital, InterWest Partners, Mayfield Fund, U.S. Bancorp, GeneChem, Pacific Venture Group, The Walden Group, A.M. Pappas Life Science Ventures, Cooper Hill Partners, The Koffler Group

## Investors

- Enterprise Partners Venture Capital (https://capitalatlas.ai/funds/enterprise-partners-venture-capital) — Series C
- InterWest Partners (https://capitalatlas.ai/funds/interwest-partners) — Series C
- Mayfield Fund (https://capitalatlas.ai/funds/mayfield-fund) — Series C
- U.S. Bancorp — Series C
- GeneChem (https://capitalatlas.ai/funds/genechem) — Series C
- Pacific Venture Group (https://capitalatlas.ai/funds/pacific-venture-group) — Series C
- The Walden Group — Series C
- A.M. Pappas Life Science Ventures — Series C
- Cooper Hill Partners — Series C
- The Koffler Group — Series C